NCT01663506View on ClinicalTrials.gov

A Non-Interventional Study in Patients With Moderate to Severe Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)

CompletedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Rheumatoid Arthritis
Trial Locations (3)

11312

Tallinn

13419

Tallinn

51014

Tartu

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01663506 - A Non-Interventional Study in Patients With Moderate to Severe Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab) | Biotech Hunter | Biotech Hunter